Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study
Beatriz López Centeno, Carlos Badenes-Olmedo, Angel Mataix-San-Juan, et al.
Clinical Infectious Diseases (2019) Vol. 71, Iss. 2, pp. 353-362
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

The challenge of HIV treatment in an era of polypharmacy
David Back, Catia Marzolini
Journal of the International AIDS Society (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 146
Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
Perrine Courlet, Françoise Livio, Monia Guidi, et al.
Open Forum Infectious Diseases (2019) Vol. 6, Iss. 12
Open Access | Times Cited: 57
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial
Paolo Maggi, Giuliano Rizzardini, Jean‐Michel Molina, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 2, pp. 775-788
Open Access | Times Cited: 42
Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic
Dario Cattaneo, Letizia Oreni, Paola Meraviglia, et al.
Drugs & Aging (2023) Vol. 40, Iss. 7, pp. 665-674
Closed Access | Times Cited: 15
Epidemiología, tratamiento y pronóstico de la infección VIH en 2024: revisión práctica
Lorena de la Mora, Josep Mallolas, Juan Ambrosioni
Medicina Clínica (2024) Vol. 162, Iss. 11, pp. 535-541
Closed Access | Times Cited: 5
[Artículo traducido] Trayectorias duales de polifarmacia e índice de complejidad farmacoterapéutico en personas que viven con infección por el virus de la inmunodeficiencia humana en España
Enrique Contreras Macías, María de las Aguas Robustillo Cortés, Ramón Morillo Verdugo
Farmacia Hospitalaria (2025)
Open Access
Treatment satisfaction and needs among people living with HIV who have incomplete viral load suppression in Japan: A multicenter, cross-sectional, observational study
Takeshi Kimura, Shinichi Hikasa, Masashi Ishihara, et al.
Journal of Infection and Chemotherapy (2025), pp. 102711-102711
Closed Access
Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study
Amy C. Justice, Kirsha S. Gordon, Jonathon Romero, et al.
The Lancet Healthy Longevity (2021) Vol. 2, Iss. 10, pp. e639-e650
Open Access | Times Cited: 24
Human Immunodeficiency Virus in Older Adults
Matthew Russell, Amy C. Justice
Clinics in Geriatric Medicine (2024) Vol. 40, Iss. 2, pp. 285-298
Closed Access | Times Cited: 3
Prescribing issues in elderly individuals living with HIV
Catia Marzolini, Françoise Livio
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 643-659
Closed Access | Times Cited: 29
Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
M Cantudo-Cuenca, Antonio Gutiérrez‐Pizarraya, Ana Pinilla-Fernández, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
High level of medication regimen complexity index correlate with worse quality of life in people living with HIV
Enrique Contreras-Macías, Antonio Gutiérrez‐Pizarraya, María de las Aguas Robustillo Cortés, et al.
Revista Española de Quimioterapia (2021) Vol. 34, Iss. 2, pp. 93-99
Open Access | Times Cited: 22
Prevalence of Potentially Clinically Significant Drug–Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the Literature
Daryl Hodge, Eva Maria Hodel, Elen Hughes, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2023) Vol. 92, Iss. 2, pp. 97-105
Open Access | Times Cited: 8
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
Elena Sánchez-Yáñez, M.J. Huertas-Fernández, María de las Aguas Robustillo Cortés, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 6, pp. 584-591
Open Access | Times Cited: 8
HIV-Associated Conditions in Older Adults
Ecler Jaqua, Wessam Labib, Katalin Danji
Cureus (2022)
Open Access | Times Cited: 13
Prevalence of Potential Drug–Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors
Elisabeth Deutschmann, Heiner C. Bucher, Steffen Jaeckel, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e2145-e2152
Open Access | Times Cited: 19
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study
María G. Cantillana-Suárez, María de las Aguas Robustillo Cortés, Antonio Gutiérrez‐Pizarraya, et al.
European Journal of Hospital Pharmacy (2021) Vol. 28, Iss. e1, pp. e157-e163
Open Access | Times Cited: 16
What is polypharmacy in people living with HIV/AIDS? A systematic review
Mohammed Danjuma, Safah Khan, Farah Wahbeh, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review
Lorena de la Mora, Josep Mallolas, Juan Ambrosioni
Medicina Clínica (English Edition) (2024) Vol. 162, Iss. 11, pp. 535-541
Closed Access | Times Cited: 2
Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
Chinyere Okoli, Achim Schwenk, M. Radford, et al.
HIV Medicine (2020) Vol. 21, Iss. 8, pp. 471-480
Open Access | Times Cited: 16
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
Mohammed Danjuma, Oyelola A. Adegboye, Ahmed Tarek Aboughalia, et al.
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 11
Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study
Lorena de la Mora, María J. Nebot, Marı́a Martı́nez-Rebollar, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 6, pp. 2111-2124
Open Access | Times Cited: 11
Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients
Jason J. Schafer, Neha Sheth Pandit, Agnes Cha, et al.
Open Forum Infectious Diseases (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Worldwide Prevalence of Polypharmacy: A Systematic Review
Beatriz Dias Januário, Natália Silva Mafra, Humberto de Souza Silva, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 8, pp. 568-586
Closed Access | Times Cited: 5
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug‐Drug Interaction Magnitudes in the Elderly
Felix Stader, Perrine Courlet, Hannah Kinvig, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 2, pp. 471-484
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top